Lord, Abbett & Co. LLC Pulmonx Corp Transaction History

Lord, Abbett & Co. LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Oct 07, 2024	BUY	$7.89 - $13.14 $2.88 Million - $4.8 Million	365,518 New	365,518 $4.66 Million
Q4 2023 Feb 12, 2024	BUY	$7.89 - $13.14 $2.88 Million - $4.8 Million	365,518 New	365,518 $4.66 Million
Q3 2022 Nov 14, 2022	BUY	$15.35 - $23.99 $1.91 Million - $2.98 Million	124,326 Added 69.32%	303,680 $5.06 Million
Q2 2022 Aug 12, 2022	BUY	$14.0 - $27.95 $169,092 - $337,580	12,078 Added 7.22%	179,354 $2.64 Million
Q1 2022 May 13, 2022	SELL	$21.13 - $35.65 $3.26 Million - $5.5 Million	-154,387 Reduced 48.0%	167,276 $4.15 Million
Q4 2021 Feb 11, 2022	SELL	$29.72 - $45.1 $116,026 - $176,070	-3,904 Reduced 1.2%	321,663 $10.3 Million
Q3 2021 Nov 09, 2021	BUY	$35.98 - $44.48 $4.47 Million - $5.52 Million	124,157 Added 61.64%	325,567 $11.7 Million
Q2 2021 Aug 11, 2021	SELL	$37.61 - $48.0 $779,504 - $994,848	-20,726 Reduced 9.33%	201,410 $8.89 Million
Q1 2021 May 11, 2021	BUY	$44.0 - $67.54 $1.1 Million - $1.69 Million	25,023 Added 12.69%	222,136 $10.2 Million
Q4 2020 Feb 09, 2021	BUY	$39.31 - $69.02 $7.75 Million - $13.6 Million	197,113 New	197,113 $13.6 Million

123

31M

300

204K

Ticker LUNG
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,268,400
Market Cap $236M
Description
Pulmonx Corporation, a medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. It offers Zephyr Endobronchial Valve, a solution for the treatment of bronchoscopic in adult patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a ...

Get notified when there are updates to the investment portfolio of Lord, Abbett & Co. LLC, based on Form 13F filings with the SEC.

Stay updated on Lord, Abbett & Co. LLC with notifications on news.